statin
- Generic Name
- statin
PCSK9 Inhibitor with Statin Therapy for Asymptomatic Intracranial Atherosclerosis
- Conditions
- Intracranial AtherosclerosisIntracranial Artery StenosisAtherosclerotic Plaque
- Interventions
- Drug: Recaticimab and Statin
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06902740
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
🇨🇳Chinese PLA General Hospital, Beijing, Beijing, China
🇨🇳Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
- First Posted Date
- 2025-01-21
- Last Posted Date
- 2025-01-21
- Target Recruit Count
- 300
- Registration Number
- NCT06785740
- Locations
- 🇳🇱
Flevoziekenhuis, Almere, Netherlands
🇳🇱Amsterdam UMC, location AMC, Amsterdam, Netherlands
🇳🇱Catharina Ziekenhuis, Eindhoven, Netherlands
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)
- Conditions
- Acute Coronary Syndromes
- Interventions
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Yun Dai Chen
- Target Recruit Count
- 6000
- Registration Number
- NCT06738758
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
- Conditions
- Myocardial Ischaemic SyndromeCoronary Heart Disease
- Interventions
- Drug: PCSK9 inhibitor
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Nanjing Medical University
- Target Recruit Count
- 400
- Registration Number
- NCT06730802
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
- Conditions
- Ischemic StrokeLipid DisorderAtherosclerosis of ArteryStatin
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 200
- Registration Number
- NCT06604117
- Locations
- 🇨🇳
Xuanwu Hospital, Xicheng District, Beijing, China
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Minia University
- Target Recruit Count
- 60
- Registration Number
- NCT06553157
- Locations
- 🇪🇬
Minia University hospital, department of oncology and nuclear medicine, Minya, Egypt
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
- Conditions
- Coronary Artery DiseaseOptical Coherence Tomography
- Interventions
- Drug: PCSK9 inhibitor
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- First Affiliated Hospital of Xinjiang Medical University
- Target Recruit Count
- 396
- Registration Number
- NCT06520904
- Locations
- 🇨🇳
First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Anhui Provincial Cancer Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT06468254
- Locations
- 🇨🇳
Anhui Cancer Hospital, Hefei, Anhui, China
Statins and Post-ERCP Acute Pancreatitis (Stark Project)
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Hospital General Universitario de Alicante
- Target Recruit Count
- 1016
- Registration Number
- NCT06367322
- Locations
- 🇪🇸
Alicante, Alicante, Spain
🇪🇸Hospital General Universitario de Alicante, Alicante, Spain
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
- Conditions
- AtherosclerosisCoronary Artery DiseaseHeart Attack
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 200
- Registration Number
- NCT06280976
- Locations
- 🇺🇸
University of Louisville School of Medicine, Division of Cardiovascular Diseases, Louisville, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.